Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

Drug resistance with monitored adherence

Details

Last nameWalter
First namePhilipp
Title(s)PhD
CountrySwitzerland
Year2013
Supervisor(s)K.Hersberger
PublisherUniversity of Basel, Switzerland
For degreePhD
Electronic linkhttp://edoc.unibas.ch/28810/
ISBN/DOIdoi: 10.5451/unibas-006161378
Current EmailVisible to members
Remarks-

Description

Drug resistance can be defined as the failure of a drug to exert its expected effect on pharmacological biomarkers and is caused by pharmacogenetic, cellular or clinical factors. Non-adherence, a common challenge in chronic outpatient therapy, and drug drug interactions (DDI) constitute two major clinical factors that contribute to drug resistance. Both can be controlled by a new technology for electronic multidrug adherence monitoring that was developed in the framework of this thesis.


Back